ClinicalTrials HQ

A Study to Evaluate the Efficacy and Safety of Ropeginterferon Alfa-2b in Essential Thrombocythaemia Patients

A Study to Evaluate the Efficacy and Safety of Ropeginterferon Alfa-2b in Essential Thrombocythaemia Patients

Active, not recruiting · NCT06514807 · Registry updated 2024-12-19
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Evaluate the Efficacy and Safety of Ropeginterferon Alfa-2b in Essential Thrombocythaemia PatientsHemic and Lymphatic Diseases, Myeloproliferative Disorders, blood coagulation disease, blood platelet disease, bone marrow disorder, essential thrombocythemia, hematologic disorder, hemorrhagic disease, thrombocytosis diseaseActive, not recruitingPhase 32024-12-19NCT06514807

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
AOP Orphan Pharmaceuticals AG5

36 results · Page 1 of 2

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
"Prof. Dr. Ion Chiricuta" Institute of Oncology, Hematology DepartmentCluj-NapocaRomania2
Bordeaux University Hospital, Haut-Leveque HospitalPessacFrance1
Careggi University Hospital, Department of HematologyFlorenceItaly1
Centre Hospitalier Universitaire De PoitiersPoitiersFrance1
Fundeni Clinical Institute, Center for Hematology and Bone Marrow TransplantationCrişanRomania1
General Hospital of Athens Alexandra, Therapeutic Clinic, Department of TherapeuticsAthensGreece1
Hannover Medical School, Clinic for haematology, haemostaseology, oncology and stem cell transplantationHanoverGermany1
Hospital Clinic of Barcelona, Department of HematologyBarcelonaSpain1
Iasi Regional Institute of Oncology, Department of HematologyIașiRomania1
Independent Public Healthcare Facility University Hospital in Krakow, Teaching Unit of the Hematology DepartmentKrakowPoland1
Johannes Wesling Hospital Minden, Department of Oncology and HematologyMindenGermany1
Medical University Innsbruck, Department of Internal Medicine V (Hematology and Oncology)InnsbruckAustria1
Medical University Vienna, Department of Internal Medicine I, Clinical Department of Hematology and HemostaseologyViennaAustria1
Morales Meseguer University General HospitalMurciaSpain1
Nicolaus Copernicus Provincial Multispecialty Oncology and Traumatology Center in Lodz, Department of Hematooncology with Subdivision of Daytime ChemotherapyLodzPoland1
Onco Card SRLBrasovRomania3
Ordensklinikum Linz GmbH Elisabethinen Hospital, Department of Internal Medicine I - Hemato-OncologyLinzAustria1
Polyclinic S. Orsola-MalpighiBolognaItaly4
Pratia Oncology KatowiceKatowicePoland2
Saint-Louis Hospital, Department of Adult HematologyParisFrance1
Semmelweis University, Department of Internal Medicine and Haematology, Division of HematologyBudapestHungary2
Umberto I Polyclinic of RomeRomeItaly1
University General Hospital "Attikon"AthensGreece2
University Hospital Aachen, Clinic of Oncology, Hematology and Stem Cell Transplantation (Medical Clinic IV)AachenGermany1
University Hospital Brno, Clinic of Internal Medicine - Hematology and OncologyBrnoCzechia3